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journal homepage: www.elsevier .com/ locat e/ idcrA 59-year-old male Torres Strait Islander presented with
reduced exercise tolerance, night sweats and weight loss of
twenty kilograms. He was a recent ex-smoker with a forty-four
pack year history and type II diabetes mellitus. Physical examina-
tion of his chest was unremarkable, but both internal jugular veins
were engorged and non-pulsatile. Imaging demonstrated bulky
mediastinal lymphadenopathy partially obstructing his superior
vena cava (SVC) and causing partial collapse of the right upper lobe
(Fig. 1A). The history, clinical ﬁndings and imaging were consistent
with a diagnosis of SVC obstruction secondary to a lung
malignancy. He was admitted to our hospital and commenced
on high dose dexamethasone. In hospital, his glycemic control
deteriorated and, although his blood pressure was 133/88 mmHg
on admission, six days later this fell abruptly to 80/40 mmHg
necessitating vasopressor support. Concurrent blood cultures grew
Burkholderia pseudomallei and repeat imaging showed enlarge-
ment of the mediastinal adenopathy and the development of a gas-
ﬁlled collection between the trachea and aorta (Fig. 1B). Intrave-
nous meropenem was commenced and his condition improved.
After three weeks the meropenem was changed to continuous
intravenous ceftazidime infusion to permit outpatient manage-
ment. After a total of four weeks of intravenous antimicrobials he
received three months of oral trimethoprim/sulphamethoxazole
with folic acid. Lymph node biopsy performed one month after his
initial presentation revealed only reactive lymphoid material with
no evidence of malignant cells. The mediastinal lymphadenopathy* Corresponding author.
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4.0/).had resolved on imaging performed at completion of antimicrobial
treatment (Fig. 1C).
Melioidosis is a tropical infection endemic in northern
Australia, Asia and South America [1]. The disease most commonly
presents with a pneumonic illness. It can, however, afﬂict almost
any organ with the skin, liver, spleen and prostate often affected.
Most cases present acutely with a septicemic illness but the
disease may have a more subacute presentation and mimic other
conditions such as malignancy or tuberculosis [2]. Acute pre-
sentations are particularly common in individuals with diabetes
mellitus, renal impairment or hazardous alcohol consumption, but
the disease can also be unmasked by exogenous immunosuppres-
sion and may be rapidly fatal without appropriate antimicrobial
therapy [3].
Instances of melioidosis presenting with isolated mediastinal
lymphadenopathy in the absence of pneumonia are rarely
described in the literature [2,3]. Although such a presentation
would more commonly be due to a sinister diagnosis – such as
malignancy – melioidosis should be considered, in the appropriate
clinical setting, as early recognition and treatment could be life-
saving.
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Fig. 1. A. Coronal images demonstrating mediastinal lymphadenopathy partially obstructing the SVC (arrow). B. Coronal images showing a gas ﬁlled collection within the
mediastinum (arrow). C. Resolution of lymphadenopathy and SVC obstruction.
M. Wilson et al. / IDCases 6 (2016) 58–59 59All authors have contributed equally to – and approve – the
manuscript.
None of the authors have any relationships or receive any
funding support which might be perceived as constituting a
conﬂict of interest.
Written informed consent for this manuscript was obtained
from the patient. The corresponding author has retained a copy of
this.References
[1] Limmathurotsakul D, Golding N, Dance DA, Messina JP, Pigott DM, Moyes CL,
et al. Predicted global distribution of Burkholderia pseudomallei and burden of
melioidosis. Nat Microbiol 2016;1(1):1–13.
[2] Chan HP, Yip HS. Mediastinal lymphadenopathy: melioidosis mimicking
tuberculosis. Trop Med Health 2015;43(2):93–4.
[3] Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of
melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl
Trop Dis 2010;4:1–11 11, article e900.
